Inventor · disambiguated record
Michael Fitzpatrick Wempe
Also filed as: WEMPE MICHAEL · WEMPE MICHAEL F · WEMPE MICHAEL FITZPATRICK
14 granted patents·11 pending applications·18 citations·filing 2005–2023
87Inventor score
Files withUNIV COLORADO REGENTS10WEMPE MICHAEL F4WEMPE MICHAEL FITZPATRICK4EASTMAN CHEM CO3J PHARMA CO LTD2
Top patents by PatentIndex Score
25 records- 0188US9353121B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2012·Granted May 31, 2016·7 cites·6 claims
- 0287US10676480B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2019·Granted Jun 9, 2020·2 cites·22 claims
- 0378US10202397B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2015·Granted Feb 12, 2019·2 cites·8 claims
- 0474USRE48557EAnti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2019·Granted May 18, 2021·0 cites·8 claims
- 0572US8263094B2Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereofWEMPE MICHAEL FITZPATRICK·Filed 2008·Granted Sep 11, 2012·2 cites·7 claims
- 0670US10005750B2Developing potent urate transporter inhibitors: compounds designed for their uricosuric actionWEMPE MICHAEL F·Filed 2011·Granted Jun 26, 2018·3 cites·10 claims
- 0769US10172835B2Anticancer agent compositionJ PHARMA CO LTD·Filed 2014·Granted Jan 8, 2019·2 cites·1 claims
- 0867US11472812B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2020·Granted Oct 18, 2022·0 cites·15 claims
- 0964US11964985B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2020·Granted Apr 23, 2024·0 cites·13 claims
- 1060US2009163449A1Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or additivesEASTMAN CHEM CO·Filed 2008·Application pending·0 cites
- 1159US10689392B2Anti-cancer compounds targeting ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2016·Granted Jun 23, 2020·0 cites·9 claims
- 1259US2025163013A1Treatment of genitourinary syndrome of menopauseUNIV COLORADO REGENTS·Filed 2023·Application pending·0 cites
- 1355US2009163603A1Sulfo-polymer powder and sulfo-polymer powder blendsEASTMAN CHEM CO·Filed 2008·Application pending·0 cites
- 1451US2007254859A1Compounds exhibiting efflux inhibitor activity and composition and uses thereofWEMPE MICHAEL F·Filed 2007·Application pending·0 cites
- 1550US12043601B2N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using sameUNIV COLORADO REGENTS·Filed 2019·Granted Jul 23, 2024·0 cites·10 claims
- 1649US12025596B26-oxo-pipecolic acid quantitation by mass spectrometryUNIV COLORADO REGENTS·Filed 2019·Granted Jul 2, 2024·0 cites·11 claims
- 1749US2022194939A1Novel compounds and methods of use treating fructose-related disorders or diseasesCOLORADO RES PARTNERS LLC·Filed 2020·Application pending·0 cites
- 1849US2006165769A1Pharmaceutical formulations containing vitamin E TPGS molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulationsHYATT JOHN A·Filed 2005·Application pending·0 cites
- 1946US2009215887A15-hydroxy-2-methyl-4h-pyran-4-one esters as novel tyrosinase inhibitorsEASTMAN CHEM CO·Filed 2008·Application pending·0 cites
- 2045US2007060610A1Methods and pharmaceutical formulations for increasing bioavailabilityWEMPE MICHAEL F·Filed 2006·Application pending·0 cites
- 2144US2012302638A1Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereofWEMPE MICHAEL FITZPATRICK·Filed 2012·Application pending·0 cites
- 2243US12458628B2Cancer therapeuticJ PHARMA CO LTD·Filed 2018·Granted Nov 4, 2025·0 cites·11 claims
- 2342US8183398B25-hydroxy-2-methyl-4H-pyran-4-one esters as novel tyrosinase inhibitorsWEMPE MICHAEL FITZPATRICK·Filed 2010·Granted May 22, 2012·0 cites·9 claims
- 2440US2008286219A1Hydroquinone derivative skin brightening compoundsWEMPE MICHAEL FITZPATRICK·Filed 2007·Application pending·0 cites
- 2533US2011150767A1Alpha-substituted and alpha-unsubstituted aromatic amino acid derivatives and compositions thereof for use to treat, diagnose, or monitor a medical conditionWEMPE MICHAEL F·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →